
Perhaps not thought of in the same biotech vein as San Francisco or Boston, Philadelphia has much to offer the life science community. Steve Doneson, an EisnerAmper LLP auditor specializing in technology and life sciences, discusses the key ingredients that make up any vital hub (workforce, tax incentives, research facilities, incubators, financing) and what the City of Brotherly Love has to offer. Steve then reads the tea leaves and gives you an idea of where this burgeoning biotech hub is headed.
Version: 20241125